Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Obstetrics & Gynecology 1997;90:240-243
© 1997 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weeks, J.
Right arrow Articles by Gall, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weeks, J.
Right arrow Articles by Gall, S.

Articles

Persistence of penicillin G benzathine in pregnant group B streptococcus carriers

JW Weeks, SR Myers, L Lasher, J Goldsmith, C Watkins, and SA Gall

OBJECTIVE: To determine if streptococcicidal levels of penicillin G benzathine can be detected in maternal serum 4 weeks after treatment with 4.8 million units. METHODS: Thirty-seven pregnant women with positive group B streptococcus vaginal or urine cultures were each given 4.8 million units of penicillin G benzathine. Maternal blood samples were collected after injection and at delivery. Serum penicillin levels were measured by high-pressure liquid chromatography. Follow-up cultures were done when possible. RESULTS: None of the patients had serum penicillin levels below 0.20 microgram/mL 30 days after treatment. Cord blood levels were approximately 50% lower than maternal levels. In all but three subjects, cord blood levels exceeded 0.06 microgram/mL, the minimal inhibitory concentration for group B streptococcus. The three exceptions were patients who delivered more than 100 days after treatment. Group B streptococcus cultures were negative at the time of delivery in 72% of cases. None of the patients with positive cultures were moderately or heavily colonized. CONCLUSION: In pregnant women, penicillin G benzathine levels are high enough to inhibit the growth of group B streptococcus for more than 4 weeks after injection with 4.8 million units. Further studies are needed to evaluate whether this regimen can prevent neonatal colonization and invasive group B streptococcus disease.


This article has been cited by other articles:


Home page
 Obstet GynecolHome page
E. L. Barber, G. Zhao, I. A. Buhimschi, and J. L. Illuzzi
Duration of Intrapartum Prophylaxis and Concentration of Penicillin G in Fetal Serum at Delivery
Obstet. Gynecol., August 1, 2008; 112(2): 265 - 270.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
R. S. Gibbs and D. J. Roberts
Case 27-2007 -- A 30-Year-Old Pregnant Woman with Intrauterine Fetal Death
N. Engl. J. Med., August 30, 2007; 357(9): 918 - 925.
[Full Text] [PDF]

Home page
 Obstet GynecolHome page
R. S. Gibbs, S. Schrag, and A. Schuchat
Perinatal Infections Due to Group B Streptococci
Obstet. Gynecol., November 1, 2004; 104(5): 1062 - 1076.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
W. E. Benitz, J. B. Gould, and M. L. Druzin
Antimicrobial Prevention of Early-onset Group B Streptococcal Sepsis: Estimates of Risk Reduction Based on a Critical Literature Review
Pediatrics, June 1, 1999; 103(6): 78e - 78.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American College of Obstetricians and Gynecologists.